Ki-Hun Kim (Kihun Kim)

ORCID

Publication Activity (10 Years)

Years Active: 2019-2023
Publications (10 Years): 9

Top Venues

Antimicrobial agents and chemotherapy

Journal of medical Internet research

RNA biology

Korea Advanced Institute of Science and Technology (PHD)

This page only lists publications with an associated author ORCID identifier.

Education History

Korea Advanced Institute of Science and Technology

South Korea

PHD :: Department of Chemistry

Korea Advanced Institute of Science and Technology

South Korea

BSC :: Department of Chemistry

Publications

Gabriel Cabot, Ki-Hun Kim, Brian L Mark, Antonio Oliver, Mazdak Khajehpour
Biochemical Insights into Imipenem Collateral Susceptibility Driven by ampC Mutations Conferring Ceftolozane/Tazobactam Resistance in Pseudomonas aeruginosa. Antimicrobial agents and chemotherapy 67 (2) (2023)
Gabriel Cabot, Ki-Hun Kim, Brian L Mark, Antonio Oliver, Mazdak Khajehpour
Biochemical Insights into Imipenem Collateral Susceptibility Driven by ampC Mutations Conferring Ceftolozane/Tazobactam Resistance in Pseudomonas aeruginosa. Antimicrobial agents and chemotherapy 67 (2) (2023)
Gabriel Cabot, Ki-Hun Kim, Brian L Mark, Antonio Oliver, Mazdak Khajehpour
Biochemical Insights into Imipenem Collateral Susceptibility Driven by ampC Mutations Conferring Ceftolozane/Tazobactam Resistance in Pseudomonas aeruginosa. Antimicrobial agents and chemotherapy (2023)
Gabriel Cabot, Ki-Hun Kim, Brian L Mark, Antonio Oliver, Mazdak Khajehpour
Biochemical Insights into Imipenem Collateral Susceptibility Driven by ampC Mutations Conferring Ceftolozane/Tazobactam Resistance in Pseudomonas aeruginosa. Antimicrobial agents and chemotherapy 67 (2) (2023)
Gabriel Cabot, Ki-Hun Kim, Brian L Mark, Antonio Oliver, Mazdak Khajehpour
Biochemical Insights into Imipenem Collateral Susceptibility Driven by ampC Mutations Conferring Ceftolozane/Tazobactam Resistance in Pseudomonas aeruginosa. Antimicrobial agents and chemotherapy 67 (2) (2023)
Gabriel Cabot, Ki-Hun Kim, Brian L Mark, Antonio Oliver, Mazdak Khajehpour
Biochemical Insights into Imipenem Collateral Susceptibility Driven by ampC Mutations Conferring Ceftolozane/Tazobactam Resistance in Pseudomonas aeruginosa. Antimicrobial agents and chemotherapy 67 (2) (2023)
Gabriel Cabot, Ki-Hun Kim, Brian L Mark, Antonio Oliver, Mazdak Khajehpour
Biochemical Insights into Imipenem Collateral Susceptibility Driven by ampC Mutations Conferring Ceftolozane/Tazobactam Resistance in Pseudomonas aeruginosa. Antimicrobial agents and chemotherapy 67 (2) (2023)
Skander Tahar Mulder, Amir-Houshang Omidvari, Anja J Rueten-Budde, Pei-Hua Huang, Ki-Hun Kim, Babette Bais, Melek Rousian, Rihan Hai, Can Akgun, Jeanine E Roeters van Lennep, Sten Paul Willemsen, Peter R Rijnbeek, David M J Tax, Marcel J T Reinders, Eric Boersma, Dimitris Rizopoulos, Valentijn T Visch, Régine Patricia Maria Steegers-Theunissen
Dynamic Digital Twin: Diagnosis, Treatment, Prediction, and Prevention of Disease During the Life Course. Journal of medical Internet research 24 (9) (2022)
Ki-Hun Kim, Jihyun Hwang, Jin Hong Kim, Kyung-Pyo Son, Yejin Jang, Meehyein Kim, Suk-Jo Kang, Jie-Oh Lee, Jin Young Kang, Byong-Seok Choi
Structural and biophysical properties of RIG-I bound to dsRNA with G-U wobble base pairs. RNA biology 17 (3) (2019)

Ki-Hun Kim.css-eqlu8i{font-size:small;padding-left:4px;} (Kihun Kim)

Publication Activity (10 Years)

Top Topics

Top Venues

Ki-Hun Kim (Kihun Kim)